When a peptide indiscriminately stimulates the release of these two hormones alongside GH, you get a cascade of unwanted effects
What results to expect and when Setting realistic expectations prevents disappointment and helps researchers evaluate whether their protocol is working
10.1210/endo.143.7.8905 33 MavalliM
A consultation with our medical team and baseline laboratory testing are required to determine if this therapy is appropriate for you.
FDA-approved GLP-1 receptor agonists include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), lixisenatide (Adlyxin), exenatide (Bydureon BCise), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist